{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:16:40Z","timestamp":1787062600547,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.eimc.2012.06.010","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T17:31:25Z","timestamp":1346261485000},"page":"4-9","source":"Crossref","is-referenced-by-count":36,"title":["Actividad de 18 agentes antimicrobianos frente a aislados cl\u00ednicos de Acinetobacter baumannii: segundo estudio nacional multic\u00e9ntrico (proyecto GEIH-REIPI-Ab 2010)"],"prefix":"10.1016","volume":"31","author":[{"given":"Felipe","family":"Fern\u00e1ndez-Cuenca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Tom\u00e1s-Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Caballero-Moyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Bou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2012.06.010_bib0005","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2012.06.010_bib0010","doi-asserted-by":"crossref","first-page":"e22674","DOI":"10.1371\/journal.pone.0022674","article-title":"Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity","volume":"6","author":"Antunes","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.eimc.2012.06.010_bib0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/iub.534","article-title":"Acinetobacter infection--an emerging threat to human health","volume":"63","author":"Visca","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.eimc.2012.06.010_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhin.2011.08.013","article-title":"Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces","volume":"80","author":"Espinal","year":"2012","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.eimc.2012.06.010_bib0025","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/AAC.01464-06","article-title":"Global challenge of multidrug-resistant Acinetobacter baumannii","volume":"51","author":"Perez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2012.06.010_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijantimicag.2011.10.004","article-title":"Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options","volume":"39","author":"Kempf","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2012.06.010_bib0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajic.2009.01.008","article-title":"Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive \u201cbundle\u201d approach","volume":"37","author":"Rodr\u00edguez-Ba\u00f1o","year":"2009","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.eimc.2012.06.010_bib0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1086\/595977","article-title":"Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital","volume":"30","author":"Valencia","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.eimc.2012.06.010_bib0045","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1517\/14656566.9.4.587","article-title":"Therapeutic options for Acinetobacter baumannii infections","volume":"9","author":"Vila","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eimc.2012.06.010_bib0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diagmicrobio.2008.11.004","article-title":"MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates","volume":"63","author":"Turner","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2012.06.010_bib0055","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.diagmicrobio.2009.08.020","article-title":"Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008)","volume":"65","author":"Rhomberg","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2012.06.010_bib0060","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)","volume":"66","author":"Gales","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2012.06.010_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1469-0691.2007.01943.x","article-title":"Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial","volume":"14","author":"Rodloff","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2012.06.010_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/cid\/cir323","article-title":"The challenges of antimicrobial drug resistance in Greece","volume":"53","author":"Miyakis","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.06.010_bib0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/cid\/ciq231","article-title":"Coexistence of blaNDM-1 with the prevalent blaOXA23 and blaIMP in pan-drug resistant Acinetobacter baumannii isolates in China","volume":"52","author":"Chen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2012.06.010_bib0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijantimicag.2010.06.049","article-title":"Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases\u2013a multicentre study","volume":"36","author":"Park","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2012.06.010_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0213-005X(04)73085-2","article-title":"Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000)","volume":"22","author":"Fern\u00e1ndez-Cuenca","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2012.06.010_bib0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1157\/13095373","article-title":"Antimicrobial resistance surveillance: VIRA STUDY 2006","volume":"24","author":"Picazo","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2012.06.010_bib0095","first-page":"166","article-title":"Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007","volume":"21","author":"Guembe","year":"2008","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.eimc.2012.06.010_bib0100","first-page":"144","article-title":"Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study","volume":"23","author":"Gimeno","year":"2010","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.eimc.2012.06.010_bib0105","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/JCM.01026-10","article-title":"Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain","volume":"49","author":"Villal\u00f3n","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2012.06.010_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/JCM.33.1.11-15.1995","article-title":"Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis","volume":"33","author":"Vaneechoutte","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2012.06.010_bib0115","doi-asserted-by":"crossref","unstructured":"Espinal P, Seifert H, Dijkshoorn L, Vila J, Roca I. Rapid and accurate identification of species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect. 2011 Oct 13. doi:10.1111\/j.1469-0691.2011.03696.x.","DOI":"10.1111\/j.1469-0691.2011.03696.x"},{"key":"10.1016\/j.eimc.2012.06.010_bib0120","series-title":"Performance standards for antimicrobial susceptibility testing; 20th information supplement (June 2010 update). M100-S20 June 2010 Update","year":"2010"},{"key":"10.1016\/j.eimc.2012.06.010_bib0125","unstructured":"Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Recommandations 2010 [consultado 9 Feb 2012]. Paris, France: Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Disponible en: http:\/\/www.sfm-microbiologie.org"},{"key":"10.1016\/j.eimc.2012.06.010_bib0130","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID); 2009 [consultado 9 Feb 2012]. Disponible en: http:\/\/www.eucast.org"},{"key":"10.1016\/j.eimc.2012.06.010_bib0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2012.06.010_bib0140","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/jac\/dkm305","article-title":"High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea","volume":"60","author":"Ko","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2012.06.010_bib0145","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jac\/dkm310","article-title":"Antimicrobial susceptibility among organisms from the Asia\/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline","volume":"60","author":"Reinert","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2012.06.010_bib0150","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jac\/dkm018","article-title":"High tigecycline resistance in multidrug-resistant Acinetobacter baumannii","volume":"59","author":"Navon-Venezia","year":"2007","journal-title":"J Antimicrob Chemother"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X12002273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X12002273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T21:01:15Z","timestamp":1594587675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X12002273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0213005X12002273"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2012.06.010","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}